Overview
The objective of the study is to constrcut a noninvasive approach 68Ga-Nb-1 PET/CT to detect the PD-L1 expression of tumor lesions in patients with solid tumors and to identify patients benefiting from anti-PD-L1 treatment.
Eligibility
Inclusion Criteria:
- Aged >18 years old; ECOG 0 or 1;
- Patients with solid tumors;
- Has at least one measurable target lesion according to Response Evaluation Criteria in Solid Tumors (RECIST V1.1);
- life expectancy >=12 weeks.
Exclusion Criteria:
- Significant hepatic or renal dysfunction;
- Is pregnant or ready to pregnant;
- Cannot keep their states for half an hour;
- Refusal to join the clinical study;
- Suffering from claustrophobia or other mental diseases;
- Any other situation that researchers think it is not suitable to participate in the experiment